TNF and TNF receptor 1-associated periodic fever syndrome: On the other hand, etanercept represents the most widely employed anti-TNF-α agent for TRAPS (1, 6, 23), as the monoclonal antibodies infliximab and adalimumab have been anecdotally associated to paradoxical inflammatory attacks in such patients (8, 9, 24).